BiosanaPharma Overview

  • Founded
  • 2012
  • Status
  • Private
  • Employees
  • 10
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $17M
Latest Deal Amount
  • Investors
  • 2

BiosanaPharma General Information


Operator of a biopharmaceutical company focused on reducing the manufacturing costs of monoclonal antibody biological drugs. The company is involved in the development and production of monoclonal antibodies with a focus on biosimilars, providing businesses with good profitability at very low drug pricing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Bargelaan 200
  • 2333 CW Leiden
  • Netherlands
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BiosanaPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 03-Dec-2020 $17M 0000 Completed Generating Revenue
4. Later Stage VC 01-Jan-2017 Completed Generating Revenue
3. Early Stage VC (Series B) 01-Dec-2015 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Jan-2015 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view BiosanaPharma’s complete valuation and funding history, request access »

BiosanaPharma Executive Team (5)

Name Title Board Seat Contact Info
Ard Tijsterman Co-Founder, Chief Executive Officer & Board Member
Jaap den Engelsman Co-Founder & Chief Financial Officer
Jaap Wieling Ph.D Co-Founder, Chief Operating Officer & Chief Scientific Officer
Maarten Pennings Chief Technology Officer
Nettie Buitelaar Ph.D Chief Customer Officer & Chief Business Officer
To view BiosanaPharma’s complete executive team members history, request access »

BiosanaPharma Board Members (4)

Name Representing Role Since
Ard Tijsterman BiosanaPharma Co-Founder, Chief Executive Officer & Board Member 000 0000
Edward Willems Self Board Member 000 0000
Engelbert Willink MD Self Board Member 000 0000
Renny Yeo BiosanaPharma Board Member 000 0000
To view BiosanaPharma’s complete board members history, request access »

BiosanaPharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BiosanaPharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Gold Nest Private Capital Venture Capital Minority 000 0000 000000 0
Cicada Innovations Accelerator/Incubator Minority 000 0000 000000 0
To view BiosanaPharma’s complete investors history, request access »

BiosanaPharma Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 01-Jan-2018 000000000000000000 Biotechnology
BiOraliX 01-Oct-2017 Joint Venture Biotechnology
To view BiosanaPharma’s complete investments and acquisitions history, request access »

BiosanaPharma Subsidiaries (1)

Company Name Industry Location Founded
00000000 Biotechnology Fochteloo, Netherlands
To view BiosanaPharma’s complete subsidiaries history, request access »